GST NO. : 27AEZFS4094K1ZY
Pharmaceutical Capsules
Leading Exporters, Wholesaler and Trader of Molnunat 200mg Molnupiravir Capsules, Pangraf 0.5mg Tacrolimus Capsules, Pregarica 300 Pregabalin Capsules and Tacrograf 0.25mg Tacrolimus Capsules from Thane.
| Business Type | Exporter, Supplier, Trader |
| Packaging Type | Box |
| Packaging Size | 40 Capsules |
| Form | Capsules |
| Usage | Treatment Of Mild To Moderate COVID-19 |
| Active Ingredient | Molnupiravir |
| Drug Class | Antiviral |
| Administration | Oral, As Prescribed By A Doctor |
| Strength | 200mg |
| Precaution | Not Recommended For Pregnant Women, Liver/kidney Disease Patients |
| Storage | Store At Room Temperature, Away From Moisture And Light |
Product Description
- Indication: Treatment of mild to moderate COVID-19
- Active Ingredient: Molnupiravir 200mg
- Drug Class: Antiviral
- Administration: Oral, as prescribed by a doctor
- Side Effects: Headache, nausea, dizziness
- Precaution: Not recommended for pregnant women, liver/kidney disease patients
- Storage: Store at room temperature, away from moisture and light
- Molnunat 200mg contains Molnupiravir, an oral antiviral medication used for the treatment of mild to moderate COVID-19 in high-risk adults to prevent severe illness and hospitalization. It works by inhibiting viral replication, reducing the spread of the virus in the body. Manufactured by Natco Pharma Ltd, Molnunat 200mg comes in 40-capsule packaging and should be taken as prescribed by a doctor. Common side effects include headache, nausea, and dizziness. This medication is not a substitute for vaccination and should be used only under medical supervision. Not recommended for pregnant women or individuals with severe liver or kidney disease.
| Business Type | Exporter, Supplier, Trader |
| Usage/Application | Prevention Of Organ Transplant Rejection |
| Dosage Form | Oral Capsule |
| Manufactured By | Panacea Biotec |
| Packaging Size | 6x10 Capsules |
| Indicated For | Prevention Of Organ Transplant Rejection |
| Active Ingredient | Tacrolimus 0.5mg |
| Benefits | Ensures Long-term Graft Survival |
| Administration | Taken Under Medical Supervision |
| Monitoring Required | Kidney Function, Blood Pressure, Drug Levels |
| Mechanism Of Action | Suppresses Immune Response To Prevent Rejection |
Product Description
- Indicated For: Prevention of organ transplant rejection
- Active Ingredient: Tacrolimus 0.5mg
- Mechanism of Action: Suppresses immune response to prevent rejection
- Dosage Form: Oral capsule
- Benefits: Ensures long-term graft survival
- Administration: Taken under medical supervision
- Monitoring Required: Kidney function, blood pressure, drug levels
- Pangraf 0.5mg contains Tacrolimus (0.5mg), an immunosuppressant used to prevent organ transplant rejection in kidney, liver, and heart recipients. It works by suppressing the immune system, reducing the risk of the body attacking the transplanted organ. Pangraf 0.5mg is also used in autoimmune conditions as prescribed by doctors. It must be taken under strict medical supervision, with regular monitoring of kidney function, blood pressure, and drug levels in the blood. Patients should follow dietary and lifestyle precautions to optimize effectiveness and minimize side effects. This medicine plays a vital role in ensuring long-term transplant success.
| Business Type | Exporter, Supplier, Trader |
| Brand Name | Pregarica |
| Form | Capsules |
| Strength | 300mg |
| Composition | Pregabalin |
| Packaging Type | Box |
| Manufactured By | Healing Pharma |
| Storage | Store In A Cool, Dry Place |
| Packaging Size | 3x0 Capsules |
| Business Type | Exporter, Supplier, Trader |
| Manufactured By | Biocon |
| Packaging Size | 10x10 Capsules |
| Usage/Application | Prevent Organ Rejection Post-transplant, Treat Severe Atopic Dermatitis |
| Packaging Type | Box |
| Side Effect | Hypertension, Kidney Issues, Increased Infection Risk |
| Dosage Form | Capsule (Oral) |
| Active Ingredient | Tacrolimus |
| Mechanism Of Action | Suppresses T-cell Activation To Prevent Immune Response |
| Administration | Taken Twice Daily, As Prescribed |
| Precaution | Requires Regular Monitoring Of Blood Levels |
Product Description
- Indication: Prevents organ rejection post-transplant
- Active Ingredient: Tacrolimus 0.25mg
- Mechanism of Action: Suppresses T-cell activation to prevent immune response
- Dosage Form: Capsule (Oral)
- Administration: Taken twice daily, as prescribed
- Side Effects: Hypertension, kidney issues, increased infection risk
- Precaution: Requires regular monitoring of blood levels
- Tacrograf 0.25mg contains Tacrolimus (0.25mg), a potent immunosuppressant derived from Streptomyces tsukubaensis. It is used primarily to prevent organ rejection in patients who have undergone liver, kidney, heart, and other organ transplants. Tacrograf works by inhibiting T-lymphocyte activation, thereby reducing the risk of the immune system attacking the transplanted organ. It is also effective in treating severe atopic dermatitis when used topically. The medication is available in capsule form and should be taken exactly as prescribed by a healthcare professional. Common side effects include hypertension, kidney dysfunction, and an increased risk of infections due to immune suppression.
